126 related articles for article (PubMed ID: 9799997)
1. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx.
Dobroś W; Ryś J; Niezabitowski A; Olszewski E
Auris Nasus Larynx; 1998 Sep; 25(3):295-301. PubMed ID: 9799997
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of PCNA expression in laryngeal cancer.
Saraç S; Ayhan A; Hosal AS; Kaya S
Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1321-4. PubMed ID: 9865753
[TBL] [Abstract][Full Text] [Related]
4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
5. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
[TBL] [Abstract][Full Text] [Related]
6. Nuclear morphometry for the prediction of regional lymph nodes metastases in patients with cancer of the larynx.
Dobroś W; Gil K; Ryś J; Stanisz-Wallis K
Otolaryngol Head Neck Surg; 2000 Dec; 123(6):770-4. PubMed ID: 11112977
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
[TBL] [Abstract][Full Text] [Related]
8. [The value of cervical lymph node ultrasound examination in patients suffering from laryngeal cancer].
Dobroś W; Pacura B; Małczak J
Przegl Lek; 2006; 63 Suppl 7():45-8. PubMed ID: 17806194
[TBL] [Abstract][Full Text] [Related]
9. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma.
Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O
Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649
[TBL] [Abstract][Full Text] [Related]
10. Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.
Moe K; Wolf GT; Fisher SG; Hong WK
Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):644-8. PubMed ID: 8639297
[TBL] [Abstract][Full Text] [Related]
11. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.
Bradford CR; Wolf GT; Carey TE; Zhu S; Beals TF; Truelson JM; McClatchey KD; Fisher SG
Otolaryngol Head Neck Surg; 1999 Nov; 121(5):534-8. PubMed ID: 10547465
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cervical lymph node metastasis of 1400 patients with cancer of the larynx.
Tomik J; Składzien J; Modrzejewski M
Auris Nasus Larynx; 2001 Aug; 28(3):233-40. PubMed ID: 11489367
[TBL] [Abstract][Full Text] [Related]
13. [Uni- and multivariate analysis of prognostic factors in T3 laryngeal cancers].
Manni JJ; Terhaard CH; de Boer MF; Croll GA; Hilgers FJ; Annyas AA; van der Meij AG; Hordijk GJ
Laryngorhinootologie; 1993 Nov; 72(11):574-9. PubMed ID: 8305123
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between tumor cell proliferating activity and biological behavior, prognosis in laryngeal carcinoma].
Zhou G; Liang C; Lin D; Zhang X; Wen D; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):178-81. PubMed ID: 10684010
[TBL] [Abstract][Full Text] [Related]
15. [Value of monoclonal antibodies (PC 10, MIB1, p53 and LeuM 1) for assessing the prognosis of patients with squamous epithelial carcinoma of the larynx after partial laser resection].
Hake R; Eckel H; von Pritzbuer E; Volling P; Thiele J
Pathologe; 1995 May; 16(3):197-203. PubMed ID: 7792271
[TBL] [Abstract][Full Text] [Related]
16. The use of nuclear morphometry for the prediction of survival in patients with advanced cancer of the larynx.
Dobroś W; Gil K; Chłap Z; Olszewski E
Eur Arch Otorhinolaryngol; 1999; 256(5):257-61. PubMed ID: 10392302
[TBL] [Abstract][Full Text] [Related]
17. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
[TBL] [Abstract][Full Text] [Related]
18. Paratracheal lymph node involvement in advanced cancer of the larynx, hypopharynx, and cervical esophagus.
Timon CV; Toner M; Conlon BJ
Laryngoscope; 2003 Sep; 113(9):1595-9. PubMed ID: 12972940
[TBL] [Abstract][Full Text] [Related]
19. [Cytokeratin antigen expression in lymph nodes--prognostic significance of clinical features of the primary tumor and lymph nodes in the presence of micrometastases in laryngeal carcinoma].
Starska K; Łukomski M; Józefowicz-Korczyńska M; Lewy-Trenda I
Przegl Lek; 2006; 63(9):748-51. PubMed ID: 17479862
[TBL] [Abstract][Full Text] [Related]
20. [Molecular prognostic markers of lymphogenous metastasis of squamous cell carcinoma of the larynx (an immuno-histochemical study)].
Kulagin RN
Vestn Otorinolaringol; 2011; (5):11-4. PubMed ID: 22334915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
